aluates Reports

$ 0.0

Global Liquid Formulations Drug Delivery Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-38T11332

Global Liquid Formulations Drug Delivery Market Research Report 2022

BUY CHAPTERS

Global Liquid Formulations Drug Delivery Market Research Report 2025

Code: QYRE-Auto-38T11332

Report

March 2025

Pages:99

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

Crescita Therpeautics

Novartis International

Boehringer Ingelheim

Pfizer Inc

Teva Pharmaceuticals

Bristol–Myers Squibb

Lead Chemical

Purdue Pharma

Glenmark Pharmaceuticals

Galderma

Johnson & Johnson Private

GlaxoSmithKline PLC

Bausch Health Companies

Hisamitsu Pharmaceuticals

Cipla Ltd

Bayer

Viatris

Liquid Formulations Drug Delivery Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Liquid Formulations Drug Delivery Market

The global market for Liquid Formulations Drug Delivery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Suspensions are defined as finely divided undissolved drugs dispersed in liquid vehicles. They can be a ready-to-use liquid suspension or a dry powder reconstitutable suspension, which is dispersed in water by the patient, a caregiver or a pharmacist. Solutions are defined as liquid preparations in which the drug and the various excipients are dissolved in the suitable solvent or aqueous system.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Liquid Formulations Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Formulations Drug Delivery.

The Liquid Formulations Drug Delivery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liquid Formulations Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Liquid Formulations Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Liquid Formulations Drug Delivery Market Report

Report Metric	Details
Report Name	Liquid Formulations Drug Delivery Market
CAGR	5%
Segment by Type	Suspensions Solutions
Segment by Application	Home Care Settings Hospitals & Clinics Burn Centers Other Facilities
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	3M, Merck & Co, Crescita Therpeautics, Novartis International, Boehringer Ingelheim, Pfizer, Teva Pharmaceuticals, Bristol Myers Squibb, Lead Chemical, Purdue Pharma, Glenmark Pharmaceuticals, Galderma, Johnson & Johnson Private, GlaxoSmithKline, Bausch Health Companies, Hisamitsu Pharmaceuticals, Cipla, Bayer, Viatris
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liquid Formulations Drug Delivery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Liquid Formulations Drug Delivery Market report?

Ans: The main players in the Liquid Formulations Drug Delivery Market are 3M, Merck & Co, Crescita Therpeautics, Novartis International, Boehringer Ingelheim, Pfizer, Teva Pharmaceuticals, Bristol Myers Squibb, Lead Chemical, Purdue Pharma, Glenmark Pharmaceuticals, Galderma, Johnson & Johnson Private, GlaxoSmithKline, Bausch Health Companies, Hisamitsu Pharmaceuticals, Cipla, Bayer, Viatris

What are the Application segmentation covered in the Liquid Formulations Drug Delivery Market report?

Ans: The Applications covered in the Liquid Formulations Drug Delivery Market report are Home Care Settings, Hospitals & Clinics, Burn Centers, Other Facilities

What are the Type segmentation covered in the Liquid Formulations Drug Delivery Market report?

Ans: The Types covered in the Liquid Formulations Drug Delivery Market report are Suspensions, Solutions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Liquid Formulations Drug Delivery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Suspensions

1.2.3 Solutions

1.3 Market by Application

1.3.1 Global Liquid Formulations Drug Delivery Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Home Care Settings

1.3.3 Hospitals & Clinics

1.3.4 Burn Centers

1.3.5 Other Facilities

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Liquid Formulations Drug Delivery Market Perspective (2020-2031)

2.2 Global Liquid Formulations Drug Delivery Growth Trends by Region

2.2.1 Global Liquid Formulations Drug Delivery Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Liquid Formulations Drug Delivery Historic Market Size by Region (2020-2025)

2.2.3 Liquid Formulations Drug Delivery Forecasted Market Size by Region (2026-2031)

2.3 Liquid Formulations Drug Delivery Market Dynamics

2.3.1 Liquid Formulations Drug Delivery Industry Trends

2.3.2 Liquid Formulations Drug Delivery Market Drivers

2.3.3 Liquid Formulations Drug Delivery Market Challenges

2.3.4 Liquid Formulations Drug Delivery Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Liquid Formulations Drug Delivery Players by Revenue

3.1.1 Global Top Liquid Formulations Drug Delivery Players by Revenue (2020-2025)

3.1.2 Global Liquid Formulations Drug Delivery Revenue Market Share by Players (2020-2025)

3.2 Global Liquid Formulations Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Liquid Formulations Drug Delivery Revenue

3.4 Global Liquid Formulations Drug Delivery Market Concentration Ratio

3.4.1 Global Liquid Formulations Drug Delivery Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Liquid Formulations Drug Delivery Revenue in 2024

3.5 Global Key Players of Liquid Formulations Drug Delivery Head office and Area Served

3.6 Global Key Players of Liquid Formulations Drug Delivery, Product and Application

3.7 Global Key Players of Liquid Formulations Drug Delivery, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Liquid Formulations Drug Delivery Breakdown Data by Type

4.1 Global Liquid Formulations Drug Delivery Historic Market Size by Type (2020-2025)

4.2 Global Liquid Formulations Drug Delivery Forecasted Market Size by Type (2026-2031)

5 Liquid Formulations Drug Delivery Breakdown Data by Application

5.1 Global Liquid Formulations Drug Delivery Historic Market Size by Application (2020-2025)

5.2 Global Liquid Formulations Drug Delivery Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Liquid Formulations Drug Delivery Market Size (2020-2031)

6.2 North America Liquid Formulations Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Liquid Formulations Drug Delivery Market Size by Country (2020-2025)

6.4 North America Liquid Formulations Drug Delivery Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Liquid Formulations Drug Delivery Market Size (2020-2031)

7.2 Europe Liquid Formulations Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Liquid Formulations Drug Delivery Market Size by Country (2020-2025)

7.4 Europe Liquid Formulations Drug Delivery Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Liquid Formulations Drug Delivery Market Size (2020-2031)

8.2 Asia-Pacific Liquid Formulations Drug Delivery Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Liquid Formulations Drug Delivery Market Size by Region (2020-2025)

8.4 Asia-Pacific Liquid Formulations Drug Delivery Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Liquid Formulations Drug Delivery Market Size (2020-2031)

9.2 Latin America Liquid Formulations Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Liquid Formulations Drug Delivery Market Size by Country (2020-2025)

9.4 Latin America Liquid Formulations Drug Delivery Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Liquid Formulations Drug Delivery Market Size (2020-2031)

10.2 Middle East & Africa Liquid Formulations Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Liquid Formulations Drug Delivery Market Size by Country (2020-2025)

10.4 Middle East & Africa Liquid Formulations Drug Delivery Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 3M

11.1.1 3M Company Details

11.1.2 3M Business Overview

11.1.3 3M Liquid Formulations Drug Delivery Introduction

11.1.4 3M Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.1.5 3M Recent Development

11.2 Merck & Co

11.2.1 Merck & Co Company Details

11.2.2 Merck & Co Business Overview

11.2.3 Merck & Co Liquid Formulations Drug Delivery Introduction

11.2.4 Merck & Co Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.2.5 Merck & Co Recent Development

11.3 Crescita Therpeautics

11.3.1 Crescita Therpeautics Company Details

11.3.2 Crescita Therpeautics Business Overview

11.3.3 Crescita Therpeautics Liquid Formulations Drug Delivery Introduction

11.3.4 Crescita Therpeautics Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.3.5 Crescita Therpeautics Recent Development

11.4 Novartis International

11.4.1 Novartis International Company Details

11.4.2 Novartis International Business Overview

11.4.3 Novartis International Liquid Formulations Drug Delivery Introduction

11.4.4 Novartis International Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.4.5 Novartis International Recent Development

11.5 Boehringer Ingelheim

11.5.1 Boehringer Ingelheim Company Details

11.5.2 Boehringer Ingelheim Business Overview

11.5.3 Boehringer Ingelheim Liquid Formulations Drug Delivery Introduction

11.5.4 Boehringer Ingelheim Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.5.5 Boehringer Ingelheim Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Liquid Formulations Drug Delivery Introduction

11.6.4 Pfizer Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.6.5 Pfizer Recent Development

11.7 Teva Pharmaceuticals

11.7.1 Teva Pharmaceuticals Company Details

11.7.2 Teva Pharmaceuticals Business Overview

11.7.3 Teva Pharmaceuticals Liquid Formulations Drug Delivery Introduction

11.7.4 Teva Pharmaceuticals Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.7.5 Teva Pharmaceuticals Recent Development

11.8 Bristol Myers Squibb

11.8.1 Bristol Myers Squibb Company Details

11.8.2 Bristol Myers Squibb Business Overview

11.8.3 Bristol Myers Squibb Liquid Formulations Drug Delivery Introduction

11.8.4 Bristol Myers Squibb Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.8.5 Bristol Myers Squibb Recent Development

11.9 Lead Chemical

11.9.1 Lead Chemical Company Details

11.9.2 Lead Chemical Business Overview

11.9.3 Lead Chemical Liquid Formulations Drug Delivery Introduction

11.9.4 Lead Chemical Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.9.5 Lead Chemical Recent Development

11.10 Purdue Pharma

11.10.1 Purdue Pharma Company Details

11.10.2 Purdue Pharma Business Overview

11.10.3 Purdue Pharma Liquid Formulations Drug Delivery Introduction

11.10.4 Purdue Pharma Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.10.5 Purdue Pharma Recent Development

11.11 Glenmark Pharmaceuticals

11.11.1 Glenmark Pharmaceuticals Company Details

11.11.2 Glenmark Pharmaceuticals Business Overview

11.11.3 Glenmark Pharmaceuticals Liquid Formulations Drug Delivery Introduction

11.11.4 Glenmark Pharmaceuticals Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.11.5 Glenmark Pharmaceuticals Recent Development

11.12 Galderma

11.12.1 Galderma Company Details

11.12.2 Galderma Business Overview

11.12.3 Galderma Liquid Formulations Drug Delivery Introduction

11.12.4 Galderma Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.12.5 Galderma Recent Development

11.13 Johnson & Johnson Private

11.13.1 Johnson & Johnson Private Company Details

11.13.2 Johnson & Johnson Private Business Overview

11.13.3 Johnson & Johnson Private Liquid Formulations Drug Delivery Introduction

11.13.4 Johnson & Johnson Private Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.13.5 Johnson & Johnson Private Recent Development

11.14 GlaxoSmithKline

11.14.1 GlaxoSmithKline Company Details

11.14.2 GlaxoSmithKline Business Overview

11.14.3 GlaxoSmithKline Liquid Formulations Drug Delivery Introduction

11.14.4 GlaxoSmithKline Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.14.5 GlaxoSmithKline Recent Development

11.15 Bausch Health Companies

11.15.1 Bausch Health Companies Company Details

11.15.2 Bausch Health Companies Business Overview

11.15.3 Bausch Health Companies Liquid Formulations Drug Delivery Introduction

11.15.4 Bausch Health Companies Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.15.5 Bausch Health Companies Recent Development

11.16 Hisamitsu Pharmaceuticals

11.16.1 Hisamitsu Pharmaceuticals Company Details

11.16.2 Hisamitsu Pharmaceuticals Business Overview

11.16.3 Hisamitsu Pharmaceuticals Liquid Formulations Drug Delivery Introduction

11.16.4 Hisamitsu Pharmaceuticals Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.16.5 Hisamitsu Pharmaceuticals Recent Development

11.17 Cipla

11.17.1 Cipla Company Details

11.17.2 Cipla Business Overview

11.17.3 Cipla Liquid Formulations Drug Delivery Introduction

11.17.4 Cipla Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.17.5 Cipla Recent Development

11.18 Bayer

11.18.1 Bayer Company Details

11.18.2 Bayer Business Overview

11.18.3 Bayer Liquid Formulations Drug Delivery Introduction

11.18.4 Bayer Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.18.5 Bayer Recent Development

11.19 Viatris

11.19.1 Viatris Company Details

11.19.2 Viatris Business Overview

11.19.3 Viatris Liquid Formulations Drug Delivery Introduction

11.19.4 Viatris Revenue in Liquid Formulations Drug Delivery Business (2020-2025)

11.19.5 Viatris Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck

Crescita Therpeautics

Novartis International

Boehringer Ingelheim

Pfizer Inc

Teva Pharmaceuticals

Bristol–Myers Squibb

Lead Chemical

Purdue Pharma

Glenmark Pharmaceuticals

Galderma

Johnson & Johnson Private

GlaxoSmithKline PLC

Bausch Health Companies

Hisamitsu Pharmaceuticals

Cipla Ltd

Bayer

Viatris

List of Tables

Table 1. Global Liquid Formulations Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Suspensions

Table 3. Key Players of Solutions

Table 4. Global Liquid Formulations Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Liquid Formulations Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Liquid Formulations Drug Delivery Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Liquid Formulations Drug Delivery Market Share by Region (2020-2025)

Table 8. Global Liquid Formulations Drug Delivery Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Liquid Formulations Drug Delivery Market Share by Region (2026-2031)

Table 10. Liquid Formulations Drug Delivery Market Trends

Table 11. Liquid Formulations Drug Delivery Market Drivers

Table 12. Liquid Formulations Drug Delivery Market Challenges

Table 13. Liquid Formulations Drug Delivery Market Restraints

Table 14. Global Liquid Formulations Drug Delivery Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Liquid Formulations Drug Delivery Market Share by Players (2020-2025)

Table 16. Global Top Liquid Formulations Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Formulations Drug Delivery as of 2024)

Table 17. Ranking of Global Top Liquid Formulations Drug Delivery Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Liquid Formulations Drug Delivery Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Liquid Formulations Drug Delivery, Headquarters and Area Served

Table 20. Global Key Players of Liquid Formulations Drug Delivery, Product and Application

Table 21. Global Key Players of Liquid Formulations Drug Delivery, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Liquid Formulations Drug Delivery Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Liquid Formulations Drug Delivery Revenue Market Share by Type (2020-2025)

Table 25. Global Liquid Formulations Drug Delivery Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Liquid Formulations Drug Delivery Revenue Market Share by Type (2026-2031)

Table 27. Global Liquid Formulations Drug Delivery Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Liquid Formulations Drug Delivery Revenue Market Share by Application (2020-2025)

Table 29. Global Liquid Formulations Drug Delivery Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Liquid Formulations Drug Delivery Revenue Market Share by Application (2026-2031)

Table 31. North America Liquid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Liquid Formulations Drug Delivery Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Liquid Formulations Drug Delivery Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Liquid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Liquid Formulations Drug Delivery Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Liquid Formulations Drug Delivery Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Liquid Formulations Drug Delivery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Liquid Formulations Drug Delivery Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Liquid Formulations Drug Delivery Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Liquid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Liquid Formulations Drug Delivery Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Liquid Formulations Drug Delivery Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Liquid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Liquid Formulations Drug Delivery Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Liquid Formulations Drug Delivery Market Size by Country (2026-2031) & (US$ Million)

Table 46. 3M Company Details

Table 47. 3M Business Overview

Table 48. 3M Liquid Formulations Drug Delivery Product

Table 49. 3M Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 50. 3M Recent Development

Table 51. Merck & Co Company Details

Table 52. Merck & Co Business Overview

Table 53. Merck & Co Liquid Formulations Drug Delivery Product

Table 54. Merck & Co Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 55. Merck & Co Recent Development

Table 56. Crescita Therpeautics Company Details

Table 57. Crescita Therpeautics Business Overview

Table 58. Crescita Therpeautics Liquid Formulations Drug Delivery Product

Table 59. Crescita Therpeautics Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 60. Crescita Therpeautics Recent Development

Table 61. Novartis International Company Details

Table 62. Novartis International Business Overview

Table 63. Novartis International Liquid Formulations Drug Delivery Product

Table 64. Novartis International Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 65. Novartis International Recent Development

Table 66. Boehringer Ingelheim Company Details

Table 67. Boehringer Ingelheim Business Overview

Table 68. Boehringer Ingelheim Liquid Formulations Drug Delivery Product

Table 69. Boehringer Ingelheim Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 70. Boehringer Ingelheim Recent Development

Table 71. Pfizer Company Details

Table 72. Pfizer Business Overview

Table 73. Pfizer Liquid Formulations Drug Delivery Product

Table 74. Pfizer Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 75. Pfizer Recent Development

Table 76. Teva Pharmaceuticals Company Details

Table 77. Teva Pharmaceuticals Business Overview

Table 78. Teva Pharmaceuticals Liquid Formulations Drug Delivery Product

Table 79. Teva Pharmaceuticals Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 80. Teva Pharmaceuticals Recent Development

Table 81. Bristol Myers Squibb Company Details

Table 82. Bristol Myers Squibb Business Overview

Table 83. Bristol Myers Squibb Liquid Formulations Drug Delivery Product

Table 84. Bristol Myers Squibb Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 85. Bristol Myers Squibb Recent Development

Table 86. Lead Chemical Company Details

Table 87. Lead Chemical Business Overview

Table 88. Lead Chemical Liquid Formulations Drug Delivery Product

Table 89. Lead Chemical Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 90. Lead Chemical Recent Development

Table 91. Purdue Pharma Company Details

Table 92. Purdue Pharma Business Overview

Table 93. Purdue Pharma Liquid Formulations Drug Delivery Product

Table 94. Purdue Pharma Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 95. Purdue Pharma Recent Development

Table 96. Glenmark Pharmaceuticals Company Details

Table 97. Glenmark Pharmaceuticals Business Overview

Table 98. Glenmark Pharmaceuticals Liquid Formulations Drug Delivery Product

Table 99. Glenmark Pharmaceuticals Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 100. Glenmark Pharmaceuticals Recent Development

Table 101. Galderma Company Details

Table 102. Galderma Business Overview

Table 103. Galderma Liquid Formulations Drug Delivery Product

Table 104. Galderma Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 105. Galderma Recent Development

Table 106. Johnson & Johnson Private Company Details

Table 107. Johnson & Johnson Private Business Overview

Table 108. Johnson & Johnson Private Liquid Formulations Drug Delivery Product

Table 109. Johnson & Johnson Private Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 110. Johnson & Johnson Private Recent Development

Table 111. GlaxoSmithKline Company Details

Table 112. GlaxoSmithKline Business Overview

Table 113. GlaxoSmithKline Liquid Formulations Drug Delivery Product

Table 114. GlaxoSmithKline Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 115. GlaxoSmithKline Recent Development

Table 116. Bausch Health Companies Company Details

Table 117. Bausch Health Companies Business Overview

Table 118. Bausch Health Companies Liquid Formulations Drug Delivery Product

Table 119. Bausch Health Companies Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 120. Bausch Health Companies Recent Development

Table 121. Hisamitsu Pharmaceuticals Company Details

Table 122. Hisamitsu Pharmaceuticals Business Overview

Table 123. Hisamitsu Pharmaceuticals Liquid Formulations Drug Delivery Product

Table 124. Hisamitsu Pharmaceuticals Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 125. Hisamitsu Pharmaceuticals Recent Development

Table 126. Cipla Company Details

Table 127. Cipla Business Overview

Table 128. Cipla Liquid Formulations Drug Delivery Product

Table 129. Cipla Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 130. Cipla Recent Development

Table 131. Bayer Company Details

Table 132. Bayer Business Overview

Table 133. Bayer Liquid Formulations Drug Delivery Product

Table 134. Bayer Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 135. Bayer Recent Development

Table 136. Viatris Company Details

Table 137. Viatris Business Overview

Table 138. Viatris Liquid Formulations Drug Delivery Product

Table 139. Viatris Revenue in Liquid Formulations Drug Delivery Business (2020-2025) & (US$ Million)

Table 140. Viatris Recent Development

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

Table 144. Authors List of This Report

List of Figures

Figure 1. Liquid Formulations Drug Delivery Picture

Figure 2. Global Liquid Formulations Drug Delivery Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Liquid Formulations Drug Delivery Market Share by Type: 2024 VS 2031

Figure 4. Suspensions Features

Figure 5. Solutions Features

Figure 6. Global Liquid Formulations Drug Delivery Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Liquid Formulations Drug Delivery Market Share by Application: 2024 VS 2031

Figure 8. Home Care Settings Case Studies

Figure 9. Hospitals & Clinics Case Studies

Figure 10. Burn Centers Case Studies

Figure 11. Other Facilities Case Studies

Figure 12. Liquid Formulations Drug Delivery Report Years Considered

Figure 13. Global Liquid Formulations Drug Delivery Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Liquid Formulations Drug Delivery Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Liquid Formulations Drug Delivery Market Share by Region: 2024 VS 2031

Figure 16. Global Liquid Formulations Drug Delivery Market Share by Players in 2024

Figure 17. Global Top Liquid Formulations Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Formulations Drug Delivery as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Liquid Formulations Drug Delivery Revenue in 2024

Figure 19. North America Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Liquid Formulations Drug Delivery Market Share by Country (2020-2031)

Figure 21. United States Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Liquid Formulations Drug Delivery Market Share by Country (2020-2031)

Figure 25. Germany Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Liquid Formulations Drug Delivery Market Share by Region (2020-2031)

Figure 33. China Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Liquid Formulations Drug Delivery Market Share by Country (2020-2031)

Figure 41. Mexico Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Liquid Formulations Drug Delivery Market Share by Country (2020-2031)

Figure 45. Turkey Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Liquid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. 3M Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 49. Merck & Co Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 50. Crescita Therpeautics Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 51. Novartis International Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 52. Boehringer Ingelheim Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 53. Pfizer Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 54. Teva Pharmaceuticals Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 55. Bristol Myers Squibb Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 56. Lead Chemical Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 57. Purdue Pharma Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 58. Glenmark Pharmaceuticals Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 59. Galderma Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 60. Johnson & Johnson Private Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 61. GlaxoSmithKline Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 62. Bausch Health Companies Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 63. Hisamitsu Pharmaceuticals Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 64. Cipla Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 65. Bayer Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 66. Viatris Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Chrysalis Oil Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26N13078

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Eucommia Ulmoides Extract Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3L13782

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global MRSA Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26S13718

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Ferrous Citrate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16S12875

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions